98 related articles for article (PubMed ID: 22010995)
1. Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.
Sardi GL; Maluenda G; Torguson R; Xue Z; Suddath WO; Kent KM; Lindsay J; Satler LF; Pichard AD; Waksman R
J Interv Cardiol; 2012 Apr; 25(2):147-55. PubMed ID: 22010995
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in diabetic versus nondiabetic patients who present with acute myocardial infarction and are treated with drug-eluting stents.
Syed AI; Ben-Dor I; Li Y; Collins SD; Gonzalez MA; Gaglia MA; Maluenda G; Delhaye C; Wakabayashi K; Bonello L; De Labriolle A; Belle L; Torguson R; Xue Z; Kaneshige K; Bernardo N; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2010 Mar; 105(6):819-25. PubMed ID: 20211325
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
7. Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction.
Sardi GL; Gaglia MA; Maluenda G; Torguson R; Laynez-Carnicero A; Ben-Dor I; Hauville C; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2012 Feb; 109(3):344-51. PubMed ID: 22112742
[TBL] [Abstract][Full Text] [Related]
8. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
9. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
[TBL] [Abstract][Full Text] [Related]
11. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
[TBL] [Abstract][Full Text] [Related]
12. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
Billinger M; Beutler J; Taghetchian KR; Remondino A; Wenaweser P; Cook S; Togni M; Seiler C; Stettler C; Eberli FR; Lüscher TF; Wandel S; Jüni P; Meier B; Windecker S
Eur Heart J; 2008 Mar; 29(6):718-25. PubMed ID: 18272504
[TBL] [Abstract][Full Text] [Related]
13. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry.
Otsuka Y; Ishiwata S; Inada T; Kanno H; Kyo E; Hayashi Y; Fujita H; Michishita I
Eur Heart J; 2011 Apr; 32(7):829-37. PubMed ID: 21196442
[TBL] [Abstract][Full Text] [Related]
14. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
[TBL] [Abstract][Full Text] [Related]
16. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
[TBL] [Abstract][Full Text] [Related]
17. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
[TBL] [Abstract][Full Text] [Related]
20. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
